Department of Renal Medicine, Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom
Hull York Medical School, Hull, United Kingdom.
Clin Med Res. 2021 Jun;19(2):54-63. doi: 10.3121/cmr.2020.1541. Epub 2021 Feb 13.
To study the impact of age, gender, and presence of diabetes (any type) on the risk of early deaths (180-day mortality) in patients starting long-term hemodialysis (HD) therapy. Systematic review of the literature. Out-patient (non-hospitalized), community-based HD therapy world-wide. Patients with advanced chronic kidney disease (CKD) starting long-term HD treatment for end-stage renal disease (ESRD). Medline and EMBASE were searched for studies published between 1/1/1985 and 12/31/2017. Observational studies involving adult subjects commencing HD were included. Data extracted included population characteristics and settings. In addition, patient or treatment related factors studied with reference to their relationship with the risk of early mortality were documented. The Quality in Prognosis Studies tool was used to assess risk of bias in individual studies. Findings were summarized, and a narrative account was drawn. Included were 26 studies (combined population 1,098,769; representing 287,085 person-years of observation for early mortality). There were 17 cohort and 9 case-control studies. Risk of bias was low in 13 and high in a further 13 studies. Patients who died in the early period were older than those who survived. Mortality rates increased with advancing age. Female gender was associated with slightly increased early mortality rates in larger and higher quality studies. The available data showed conflicting results in relation to the association of diabetes and risk of early mortality. This systematic review evaluated the impact of key demographic and co-morbid factors on risk of early mortality in patients starting maintenance HD. The information could help in delivering more tailored prognostic information and planning of future interventions.
研究年龄、性别和糖尿病(任何类型)存在与否对开始长期血液透析(HD)治疗的患者早期死亡(180 天死亡率)风险的影响。对文献进行系统评价。全世界门诊(不住院)、基于社区的 HD 治疗。患有晚期慢性肾脏病(CKD)并开始长期 HD 治疗终末期肾脏疾病(ESRD)的患者。在 1985 年 1 月 1 日至 2017 年 12 月 31 日期间发表的研究中搜索了 Medline 和 EMBASE。包括涉及开始 HD 的成年患者的观察性研究。提取的数据包括人口特征和环境。此外,还记录了与早期死亡率风险相关的患者或治疗相关因素的研究。使用预后研究质量工具评估了个别研究的偏倚风险。总结研究结果并绘制叙述性描述。共纳入 26 项研究(总人群 1098769 例;代表早期死亡率的 287085 人年观察)。有 17 项队列研究和 9 项病例对照研究。13 项研究的偏倚风险低,另外 13 项研究的偏倚风险高。早期死亡的患者比存活的患者年龄更大。死亡率随年龄增长而增加。在更大规模和更高质量的研究中,女性性别与早期死亡率略有增加相关。现有数据显示,糖尿病与早期死亡率之间的关联存在矛盾结果。本系统评价评估了开始维持性 HD 的患者的关键人口统计学和合并症因素对早期死亡风险的影响。这些信息可以帮助提供更具针对性的预后信息并规划未来的干预措施。